TickerFactsScreenerDevelopers

Cardiff Oncology, Inc. (CRDF) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2000: $27.2K2001: -$240.4K2002: -$719.4K2003: -$1.20M2004: -$1.58M2005: $3.19M2006: $3.48M2007: -$1.65M2008: -$4.05M2009: -$3.79M2010: -$5.00M2011: -$4.23M2012: $2.17M2013: $20.39M2014: $8.35M2015: $48.70M2016: $19.77M2017: $6.51M2018: $10.08M2019: $7.31M2020: $128.16M2021: $140.42M2022: $106.34M2023: $69.74M2024: $82.95M2025: $45.39M$45.39M
2000Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$45.39M-45.3%
2024$82.95M+18.9%
2023$69.74M-34.4%
2022$106.34M-24.3%
2021$140.42M+9.6%
2020$128.16M+1652.7%
2019$7.31M-27.5%
2018$10.08M+55.0%
2017$6.51M-67.1%
2016$19.77M-59.4%
2015$48.70M+483.3%
2014$8.35M-59.1%
2013$20.39M+840.1%
2012$2.17M+151.3%
2011-$4.23M+15.3%
2010-$5.00M-31.9%
2009-$3.79M+6.5%
2008-$4.05M-145.9%
2007-$1.65M-147.3%
2006$3.48M+9.1%
2005$3.19M+302.2%
2004-$1.58M-32.0%
2003-$1.20M-66.1%
2002-$719.4K-199.3%
2001-$240.4K-982.4%
2000$27.2K—